Carcinoma de células renales metastásicoFase 2NCT07123090
A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
Sasanlimab, Palbociclib, Axitinib
38 estudios de fase 2 reclutando ahora mismo, los actualizados más recientemente primero.
Abrir la página de fase 2 · una lista solo de esos estudios
Triangle is made by Triangle Health, Inc.
Riñón y vejiga38 estudios
Carcinoma de células renales metastásicoFase 2NCT07123090
Sasanlimab, Palbociclib, Axitinib
IvonescimabFase 2NCT06940518
Ivonescimab
Advanced Clear Cell Renal Cell CarcinomaFase 2NCT05361720
Cabozantinib, Ipilimumab, Nivolumab
Nonmuscle-invasive Bladder CancerFase 2NCT06971614
T3011
Adenocarcinoma of the BladderFase 2NCT06041503Artículos
Pembrolizumab, Enfortumab vedotin
Cáncer de vejigaFase 2NCT07762586
Neoadjuvant Therapy, Upfront radical cystectomy
Muscle-Invasive Bladder CarcinomaFase 2NCT06417190
Trimodal therapy (TMT) within 45 days of neoadjuvant chemotherapy (NAC)
Carcinoma de células renales metastásicoFase 2NCT05263050
Cabozantinib, Nivolumab
Clear Cell Renal Cell Cancer (ccRCC)Fase 2NCT07043608
Zanzalintinib, Investigator Choice of Bone Strengthening Agents (BSA), Non-Investigational Radiation Therapy (RT), Bone Scan
Urothelial CarcinomaFase 2NCT04879329
disitamab vedotin, pembrolizumab
Oligometastatic Renal Cell CarcinomaFase 2NCT06004336
Pembrolizumab, Radiation therapy
Renal Pelvis and Ureter Urothelial CarcinomaFase 2NCT05775471
Biopsy, Biospecimen Collection, Enfortumab Vedotin, MR Urography
Small Cell Neuroendocrine Carcinoma of BladderFase 2NCT05312671
Atezolizumab, Carboplatin, Cisplatin, Etoposide
Metastatic Bladder Urothelial CarcinomaFase 2NCT06630416
Biospecimen Collection, Computed Tomography, Pemetrexed